Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Our services

What is Motor Neurone Disease?


Motor Neurone Disease (MND) is a progressive neurodegenerative disease that attacks the upper and lower motor neurones. Degeneration of the motor neurones leads to weakness and wasting of muscles, causing increasing loss of mobility in the limbs, and difficulties with speech, swallowing and breathing.

Speech and Language Therapy and MND

MND can cause communication difficulties (such as dysarthria) and difficulties eating/drinking (known as dysphagia).

Click here for further information on Dysphagia

Click here for further information on Dysarthria

The speech and language therapist helps a person with MND as their speech and swallow alters over the course of the illness. This involves assessing the person's communication and swallow in order to provide the necessary advice and support. This may include suggesting modified diet and fluids and/or assessing a person for a communication aid.

At York Hospital, the Speech and Language therapist works as part of a multidisciplinary team caring for people with MND.

Further information regarding MND and Speech and Language Therapy can be found atwww.mndassociation.org


To return to the Speech and Language Therapy home page click here.

A receptionist at an information stand reading some paperwork

Your Visit

Looking down a long bright hospital corridor with treatment rooms on the left and windows on the right. At the bottom of the corridor is one member of staff in a blue nursing uniform

Our Hospitals

Chinese Poland

View all languages >

Visiting update

To protect our patients, staff, visitors and the community, we are again restricting visitors to all our hospitals sites so please read our latest guidance for full details before coming to our hospitals.

The decision to restrict visitors during this time has been very difficult and made only after careful consideration as we witness wider social restrictions to prevent the spread of COVID-19 in light of the highly transmissible OMICRON variant.  The guidance will be reviewed regularly.